DASI Dimensions vs ElucidVivo A.3

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

DASI Dimensions

by DASI Dimensions

ElucidVivo A.3

by Elucid

AI Verdict

Tool A (DASI Dimensions) is specifically designed for pre-procedural planning of Transcatheter Aortic Valve Replacement (TAVR) by providing precise measurements of cardiac structures from CT scans. In contrast, Tool B (ElucidVivo A.3) focuses on the quantitative analysis of arterial plaque composition and stability from CT angiography to aid in atherosclerosis patient stratification. While both utilize AI for cardiovascular imaging analysis, their distinct applications target different aspects of cardiac and vascular disease management.

Choose DASI Dimensions if…

Choose DASI Dimensions if your primary need is precise, AI-powered pre-procedural planning for Transcatheter Aortic Valve Replacement (TAVR) procedures. This tool excels at providing accurate measurements and interactive visualizations of cardiac structures from CT scans, streamlining the planning process and enhancing decision-making for interventional cardiologists.

View DASI Dimensions →

Choose ElucidVivo A.3 if…

Choose ElucidVivo A.3 if your focus is on advanced quantitative analysis of arterial plaque composition and stability from CT angiography. This system is ideal for stratifying atherosclerosis patients and optimizing treatment decisions by providing detailed visualization and measurement of plaque characteristics, including LRNC and calcifications, validated against histology.

View ElucidVivo A.3 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	DASI Dimensions	ElucidVivo A.3
Deployment	Unknown	Cloud and on-premise secure deployment.
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

DASI Dimensions

DASI Dimensions has undergone human factors evaluation and is explicitly described as user-friendly, reducing use-related risk and eliminating time spent on manual measurements. Its cloud-based, interactive platform further enhances ease of use and efficiency for pre-procedural planning.

Clinical Value

ElucidVivo A.3

Both tools are FDA-cleared and offer significant clinical value in their respective domains. However, ElucidVivo A.3 stands out with its histology-validated quantitative analysis of arterial plaque composition and the ability to non-invasively derive fractional flow reserve (FFRct) from CT scans, providing critical insights for atherosclerosis patient stratification and treatment optimization that traditionally required invasive procedures.

Pricing & Value

ElucidVivo A.3

While DASI Dimensions offers transparent 'pay per analysis' pricing, ElucidVivo A.3's recent achievement of a Category I CPT code for its quantitative coronary plaque analysis significantly enhances its value proposition by ensuring widespread reimbursement from major payors. This broad reimbursement makes the economic value and adoption potential for ElucidVivo A.3 very strong, despite its 'contact for pricing' model.

Enterprise Readiness

ElucidVivo A.3

Both are FDA-cleared and offer cloud-based deployment. ElucidVivo A.3, however, explicitly details DICOM integration, PACS/EMR interoperability, and states 'SOC 2 / HIPAA-aligned data protection'. These explicit assurances regarding integration and advanced security compliance make it more readily adaptable and trustworthy for enterprise healthcare environments.

Innovation

ElucidVivo A.3

Both tools leverage AI for advanced cardiovascular imaging. ElucidVivo A.3 demonstrates superior innovation through its unique histology-validated plaque characterization and the non-invasive derivation of FFRct from CT angiography, offering a groundbreaking approach to assessing lesion-specific ischemia without invasive catheterization. This provides a deeper, more comprehensive understanding of atherosclerosis than previously possible non-invasively.

Support & Docs

Tie

Neither the provided structured facts nor the web search results offer sufficient specific details regarding the depth, availability, or quality of customer support and documentation for either DASI Dimensions or ElucidVivo A.3. Both companies offer general contact information and demo requests, but a direct comparison of support services or comprehensive documentation is not possible with the available data.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	DASI Dimensions	ElucidVivo A.3
Product Name	DASI Dimensions	ElucidVivo A.3
Company	DASI Simulations	Elucid Bioimaging
Primary Clinical Application	Pre-procedural planning for Transcatheter Aortic Valve Replacement (TAVR) procedures.	Quantitative analysis of arterial plaque composition and stability for atherosclerosis patient stratification and treatment optimization.
Targeted Medical Specialties	Cardiology, Cardiothoracic Surgery, Radiology	Cardiology, Radiology, Vascular Surgery
Core AI Analysis Focus	AI-powered image post-processing for cardiac structures.	AI-powered quantitative analysis of arterial plaque.
Key Measurements/Outputs	Pre-defined images and measurements (diameters, lengths, angles, areas, perimeters) of cardiovascular structures.	Quantifies Lipid-Rich Necrotic Core (LRNC), matrix, and calcifications; derives fractional flow reserve (FFRct).
Validation/Quality Assurance	Human-in-the-loop quality checks for accuracy and reliability.	Validated on ground-truth histology.

Videos

Demos, reviews, and walkthroughs featuring DASI Dimensions and ElucidVivo A.3.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications of DASI Dimensions versus ElucidVivo A.3?

DASI Dimensions is designed for pre-procedural planning of Transcatheter Aortic Valve Replacement (TAVR) procedures, providing precise measurements and visualizations of cardiac structures from CT scans. In contrast, ElucidVivo A.3 focuses on quantitative analysis of arterial plaque composition and stability from CT angiography to assist physicians in atherosclerosis patient stratification and optimize treatment decisions.

What specific measurements and analyses do these tools provide?

DASI Dimensions provides pre-defined images and measurements, including diameters, lengths, angles, areas, and perimeters of cardiovascular structures. ElucidVivo A.3 objectively quantifies Lipid-Rich Necrotic Core (LRNC), matrix, and calcifications from CT images, visualizes lesion-level plaque composition, and derives fractional flow reserve (FFRct) based on vessel wall vasodilative capacity.

How do these tools ensure the accuracy or reliability of their results?

DASI Dimensions incorporates human-in-the-loop quality checks for accuracy and reliability. ElucidVivo A.3's plaque characteristic measurements are validated against histology.

Which medical specialties are these tools primarily intended for?

DASI Dimensions is primarily for Cardiology, Cardiothoracic Surgery, and Radiology. ElucidVivo A.3 is primarily for Cardiology, Radiology, and Vascular Surgery.